Understanding how a protein regulates iron levels in the body

Regulation of hepatic hepcidin expression by transferrin receptor-2

NIH-funded research Oregon Health & Science University · NIH-10901982

This study is looking at how a protein called transferrin receptor-2 helps control iron levels in people with hereditary hemochromatosis, and it hopes to find new ways to improve treatment for issues caused by too much iron in the body, like liver problems and diabetes.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionOregon Health & Science University NIH-funded
Lab location1 site (Portland, United States)
Project IDNIH-10901982 on NIH RePORTER

What this research studies

This research investigates the role of transferrin receptor-2 (TfR2) in managing iron levels in the body, particularly in patients with hereditary hemochromatosis (HH). By using advanced techniques such as adeno-associated viral vectors and protein interaction assays, the study aims to uncover how mutations in TfR2 and related proteins disrupt iron homeostasis. The findings could lead to better understanding and potential treatments for conditions caused by iron overload, such as liver disease and diabetes.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals diagnosed with hereditary hemochromatosis or those with related iron overload conditions.

Not a fit: Patients without hereditary hemochromatosis or those not experiencing iron overload may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for patients suffering from iron overload disorders.

How similar studies have performed: Previous research has shown promising results in understanding iron regulation mechanisms, suggesting that this approach could yield valuable insights.

Where this research is happening

Portland, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alcoholic Liver Diseases
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.